Contribute Try STAT+ Today

Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle of the week is already here, which means there is much to do. No doubt, you can relate on some level. So please join us as we grab a cup of stimulation — butter pecan is the choice today — and tackle the Zoom calls and deadlines that are piling up. Meanwhile, here is the latest grab bag of items of interest to help you along. Hope you conquer the world today, and do stay in touch. …

The Biden administration is expected to call for a third Covid-19 shot for Americans who were fully vaccinated with the two-shot regimen, citing the threat from the highly contagious Delta variant and heightened concerns over data showing initial immunity wanes over time, The Wall Street Journal reports. The announcement is likely to cover more than 155 million people in the U.S. who have been fully vaccinated with vaccines from Pfizer (PFE) and its partner, BioNTech (BNTX), and from Moderna (MRNA).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment